Sacklers Would Give Up Ownership of Purdue Pharma Under Settlement Proposal

The company is in discussions to resolve thousands of lawsuits. Participants in the talks value the plan at between $10 billion and $12 billion. JAN HOFFMAN https://ift.tt/30Fr9MV https://ift.tt/33ZPRd3 The New York Times Health Suits and Litigation (Civil), Pain-Relieving Drugs, Opioids and Opiates, Drugs (Pharmaceuticals), your-feed-healthcare August 27, 2019 at 02:00AM